Mohammed E Alomar (Mohammed Alomar)

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

This page only lists publications with an associated author ORCID identifier.

Publications

Sanjay Chandrasekhar, Matthew Perez, Zurain Niaz, Jahanzaib Ekram, Neelam Lal, Sarah Koly, Biwei Cao, Jonathan S Zager, Mohammed E Alomar
Troponin Elevation in Patients Undergoing Percutaneous Hepatic Perfusion for Metastatic Uveal Melanoma. Cancer control : journal of the Moffitt Cancer Center 31 (2024)
Samia Shabnaz, Trang N Nguyen, Roy Williams, Samuel M Rubinstein, Timothy J Garrett, Marwa Tantawy, Michael G Fradley, Mohammed E Alomar, Kenneth H Shain, Rachid C Baz, Daniel Lenihan, Robert Frank Cornell, Qing Lu, Yan Gong
Metabolomic signatures of carfilzomib-related cardiotoxicity in patients with multiple myeloma. Clinical and translational science 17 (5) (2024)
Sanjay Chandrasekhar, Matthew Perez, Zurain Niaz, Jahanzaib Ekram, Neelam Lal, Sarah Koly, Biwei Cao, Jonathan S Zager, Mohammed E Alomar
Troponin Elevation in Patients Undergoing Percutaneous Hepatic Perfusion for Metastatic Uveal Melanoma. Cancer control : journal of the Moffitt Cancer Center 31 (2024)
Samia Shabnaz, Trang N Nguyen, Roy Williams, Samuel M Rubinstein, Timothy J Garrett, Marwa Tantawy, Michael G Fradley, Mohammed E Alomar, Kenneth H Shain, Rachid C Baz, Daniel Lenihan, Robert Frank Cornell, Qing Lu, Yan Gong
Metabolomic signatures of carfilzomib-related cardiotoxicity in patients with multiple myeloma. Clinical and translational science 17 (5) (2024)
Samia Shabnaz, Trang N Nguyen, Roy Williams, Samuel M Rubinstein, Timothy J Garrett, Marwa Tantawy, Michael G Fradley, Mohammed E Alomar, Kenneth H Shain, Rachid C Baz, Daniel Lenihan, Robert Frank Cornell, Qing Lu, Yan Gong
Metabolomic signatures of carfilzomib-related cardiotoxicity in patients with multiple myeloma. Clinical and translational science 17 (5) (2024)